Which of the following is a characteristic of dexmedetomidine (Precedex)?

Prepare for the ABRET CNIM Exam. Use flashcards and multiple choice questions, each with explanations. Ready yourself for the exam day!

Multiple Choice

Which of the following is a characteristic of dexmedetomidine (Precedex)?

Dexmedetomidine is known for its unique properties as a sedative and analgesic, particularly its ability to mimic normal sleep. This characteristic is significant because it has a calming effect that helps to maintain a more natural sleep state compared to other sedatives. It induces sedation without causing the level of respiratory depression often associated with other agents, making it particularly useful in a variety of clinical settings, especially in intraoperative monitoring where patient stability is crucial. This sleep-like state is achieved through its action as an alpha-2 adrenergic agonist, which contributes to a reduction in sympathetic outflow and helps facilitate a more natural sleep pattern. Patients receiving dexmedetomidine tend to exhibit a more easily arousable state, contrasting with the deeper, unresponsive state often seen with traditional anesthetic agents. The other characteristics listed—inducing amnesia, being an NMDA antagonist, and acting as a GABAergic drug—do not align with the pharmacological profile of dexmedetomidine. While some medications (like benzodiazepines) can induce amnesia and act on GABA receptors, dexmedetomidine operates through a different mechanism and does not have significant NMDA receptor antagonism.

Dexmedetomidine is known for its unique properties as a sedative and analgesic, particularly its ability to mimic normal sleep. This characteristic is significant because it has a calming effect that helps to maintain a more natural sleep state compared to other sedatives. It induces sedation without causing the level of respiratory depression often associated with other agents, making it particularly useful in a variety of clinical settings, especially in intraoperative monitoring where patient stability is crucial.

This sleep-like state is achieved through its action as an alpha-2 adrenergic agonist, which contributes to a reduction in sympathetic outflow and helps facilitate a more natural sleep pattern. Patients receiving dexmedetomidine tend to exhibit a more easily arousable state, contrasting with the deeper, unresponsive state often seen with traditional anesthetic agents.

The other characteristics listed—inducing amnesia, being an NMDA antagonist, and acting as a GABAergic drug—do not align with the pharmacological profile of dexmedetomidine. While some medications (like benzodiazepines) can induce amnesia and act on GABA receptors, dexmedetomidine operates through a different mechanism and does not have significant NMDA receptor antagonism.

More practice questions